Although radiotherapy improves survival in patients, glioblastoma multiformes (GBMs) tend to relapse with augmented tumor migration and invasion even after ionizing radiation (IR). Aberrant nuclear factor-kB (NF-kB) and signal transducer and activator of transcription factor 3 (Stat3) activation and interaction have been suggested in several human tumors. However, possible NF-kB/Stat3 interaction and the role of Stat3 in maintenance of NF-kB nuclear retention in GBM still remain unknown. Stat3 and NF-kB (p65) physically interact with one another in the nucleus in glioma tumors. Most importantly, glutathione S-transferase pull-down assays identified that Stat3 binds to the p65 transactivation domain and is present in the NF-kB DNA-binding complex. Irradiation significantly elevated nuclear phospho-p65/phospho-Stat3 interaction in correlation with increased intercellular adhesion molecule-1 (ICAM-1) and soluble-ICAM-1 levels, migration and invasion in human glioma xenograft cell lines 4910 and 5310. Chromatin immunopreicipitation and promoter luciferase activity assays confirmed the critical role of adjacent NF-kB ( þ 399) and Stat3 ( þ 479) binding motifs in the proximal intron-1 in elevating IR-induced ICAM-1 expression. Specific inhibition of Stat3 or NF-kB with Stat3.siRNA or JSH-23 severely inhibited IR-induced p65 recruitment onto ICAM-1 intron-1 and suppressed migratory properties in both the cell lines. On the other hand, Stat3C-or IR-induced Stat3 promoter recruitment was significantly decreased in p65-knockdown cells, thereby suggesting the reciprocal regulation between p65 and Stat3. We also observed a significant increase in NF-kB enrichment on ICAM-1 intron-1 and ICAM-1 transactivation in Stat3C overexpressing cells. In in vivo orthotopic experiments, suppression of tumor growth in Stat3.si þ IR-treated mice was associated with the inhibition of IR-induced p-p65/p-Stat3 nuclear colocalization and ICAM-1 levels. To our knowledge, this is the first study showing the crucial role of NF-kB/Stat3 nuclear association in IR-induced ICAM-1 regulation and implies that targeting NF-kB/Stat3 interaction may have future therapeutic significance in glioma treatment.
INTRODUCTION
Glioblastoma multiforme (GBM) is a lethal human brain tumor with a mean survival rate of o1 year despite the use of aggressive postsurgical multimodal treatments, including ionizing radiation (IR) and chemotherapy. [1] [2] [3] Although locoregional radiotherapy improves survival in patients, GBMs tend to relapse in close proximity to the resection cavity after IR treatment. 4 Tumor recurrence due to escape of IR-induced growth arrest is, in part, attributed to the excessive secretion of proteases, cytokines and growth factors from the irradiated tumor cells into the extracellular milieu accompanied by inflammation. 5, 6 Nuclear factor-kB (NF-kB) is a central signaling hub in inflammation-induced carcinogenesis and maintenance of established cancers. [7] [8] [9] NF-kB is a family of five dimeric transcription factors (TFs), which contain Rel-homology domain (RHD). Among these, RelA (p65), RelB and c-Rel possess an additional c-terminal transactivation domain (TAD). Various stimuli, including UV or X-ray irradiation, cause genotoxic stress, IkB kinasemediated ubiquitination and degradation of IkBs and lead to nuclear translocation of NF-kB, which undergoes further posttranslational modifications and binds to the kB consensus elements in the target gene promoters. [10] [11] [12] Acetyltransferase p300/CBP (cAMP response element binding (CREB)-binding protein) cofactors mediate acetylation of p65, which, in turn, is deacetylated by histone deacetylases. 13, 14 This reversible acetylation is crucial for high nuclear import/export ratios and constant in/out shuttling of NF-kB.
increased tumor malignancy and poor prognosis. 19 GBMs are characterized by significant ICAM-1 expression levels, and IR elevates serum soluble-ICAM-1 levels, suggesting a role of ICAM-1 in post-irradiation tumor malignancy. [20] [21] [22] ICAM-1 promoter possesses consensus elements for specificity protein 1 (SP-1), activator protein 1 (AP-1), NFATc1 (nuclear factor of activated T cells) and NF-kB TFs upstream to the transcriptional start site. 23, 24 The significance of p65/NFATc1 cooperativity by binding to ICAM-1 intron in the regulation of thrombin-induced ICAM-1 was reported in endothelial cells. 25 Our analysis of the ICAM-1 5 0 -regulatory region revealed the presence of putative Stat-and NFkB-binding sites in the intron-1 of ICAM-1. In this study, we show that the p65-TAD domain is essential for Stat3 interaction. Promoter reporter studies suggested that the intronic region possessing putative adjacent NF-kB ( þ 399) and Stat3 ( þ 479) consensus elements is central to IR-induced ICAM-1 expression. Our in vitro and in vivo studies indicated that IR activated Stat3 and NF-kB in glioma xenograft cells and suggested the crucial role of NF-kB/Stat3 physical association in the regulation of ICAM-1-mediated migration and invasion. 
RESULTS

Stat3 directly interacts with NF-kB (p65)
. To further map the specific interacting regions on Stat3 and p65, we tested the ability of different biotin-labeled p65-and Stat3-truncated mutants to bind to GST-Stat3 and GST-p65, respectively. GST-Stat3 specifically interacted with the c-terminal region of the p65 protein comprising a transactivation domain (TAD, 291-551 aa). Conversely, Stat3 binding to the RHD domain (1-290aa) was not detected (right panel, Figure 1d ). On the other hand, GST-p65 bound to the 1-460 aa region of Stat3. Further, the region 1-120 aa did not show binding with p65, indicating the importance of coiled-coil and DNA-binding domains of Stat3 in p65 coupling (left panel, Figure 1d ). Collectively, these results confirm that Stat3 directly binds to the TAD domain within p65 (Figure 1e ). To check whether the NF-kB DNA-binding activity requires its interaction with Stat3 or p300, electrophoretic mobility shift assay (EMSA) was performed using 4910 and 5310 nuclear extracts. Pre-incubation with anti-Stat3 and anti-p300 antibodies significantly abrogated the NF-kB-binding activity and resulted in a gel super-shift, thereby confirming the presence of Stat3 and p300 in the NF-kB-DNA complex (Figure 1f ). These results suggest that Stat3 interaction with p65-TAD is required for the maintenance of constitutive NF-kB DNA-binding activity in glioma xenograft cells.
Enhanced nuclear Stat3/p65 binding in IR-treated glioma xenograft cells IR-treated cells displayed enhanced nuclear translocation of both Stat3 and NF-kB (p65) after 24 h (Figure 2a ). We observed a dosedependent increase in p-Stat3, p-p65 and ace-p65 levels, with an optimum elevation observed at 8 Gy in both the cell lines (Supplementary Figure S1a) . Based on previous reports on the role of p65/Stat3 interaction in maintaining consistent p65 activation and nuclear retention, we attempted to check the effect of IR on p65/Stat3 interaction in possible correlation with post-IR-enhanced malignancy. 18, 26 Immunofluorescence analysis showed elevated nuclear p65/Stat3 colocalization in the 6-and 12-h IR-treated cells (Supplementary Figure S1b) . Nuclear colocalization of p65/Stat3 was also evident after 24 h in both the cell lines, suggesting that IR leads to constitutive nuclear interaction of these TFs (Figure 2b ). Further, co-IP using nuclear extracts showed elevated p-Stat3/p-p65 and p-Stat3/ace-p65 binding in IR-treated cells compared with controls ( Figure 2c ). There was also an increased co-precipitation of p-p65 with p-Stat3 and p300 acetyl transferase in IR-treated cells (Figure 2d ). These results were also verified by co-IP with acetyl-p65 antibodies (Figure 2e ). Nuclear p-Stat3/p-p65 complex formation was also confirmed by co-IP in glioma cell lines U87MG, U251 and SNB19 (Supplementary Figure  S2a) . Co-IP with anti-Stat3 and anti-p65 antibodies in normal brain tissues and glioma patient biopsies (GBM) also confirmed high p65/Stat3 nuclear interaction in GBM samples (Supplementary Figure S2b) . Additionally, studies with human glioma tissue array showed significant nuclear colocalization of p-Stat3/p-p65 proteins, suggesting a possible functional role of NF-kB/Stat3 association in GBM tumors (Supplementary Figure S2c) . Immunopositivity of p-Stat3/p-p65 colocalization was increased in correlation with increasing GBM pathological grades (Supplementary Figure S2d) .
Radiation enhanced adhesion, invasion and migratory properties of cells in correlation with increased cellular-ICAM-1 and soluble-ICAM-1 levels We observed noticeable increases in the invasive potential of IRtreated 4910 and 5310 cells to B39.0% and B37.5%, respectively ( Figure 3a) . The relative migration distances in IR-treated 4910 and 5310 cells were increased by B38% and B37%, respectively (Figure 3b) . Additionally, the percentage of cell adhesion in IR-treated 4910 (B29%, B48%, B46% and B43%) and 5310 cells (B30%, 44%, 43% and 39%) was significantly increased on CN (collagen type-1), VN (vitronectin), FN (fibronectin) and MG (matrigel), respectively (Supplementary Figure S3) . IR remarkably enhanced the VN adhesion followed by adhesion on FN among the different extracellular matrix components tested. Increased invasiveness in IRtreated cells was in correlation with significant elevation in ICAM-1 transcription (Figure 3c ) and protein levels (Figure 3d ). Western blotting (WB) using conditioned media indicated a dose-dependent upregulation of sICAM-1 in IR-treated cells after 24 h. As shown in Figure 3e , IR elevated ICAM-1 expression and prominent membrane localization at the migratory edges compared with basal expression levels in untreated controls. Significant increase in ICAM-1 membrane localization in IR-treated cells was also confirmed by WB using membrane proteins (Figure 3f ). Radiation-induced ICAM-1 upregulation directly indicated its promoter transactivation by enhanced TF binding in IR-treated cells.
Strong recruitment of NF-kB and Stat3 to the ICAM-1 proximal intron-1 in IR-treated cells Based on IR-induced ICAM-1 upregulation, we attempted to elucidate the underlying molecular mechanism involved in the potentiating effect of IR on ICAM-1 transactivation by promoter analysis. We identified putative Stat-and NF-kB-binding sites in a span of B1.0 kb (http://www.cbrc.jp-/research/db/TFSEARCH). Figure 4a schematically represents the putative NF-kB (kB) and Stat (gamma-interferon activated sequence) binding motifs on the human ICAM-1 gene (Supplementary Table S1 ). Based on the presence of three potential Stat-and four NF-kB-binding sites, we divided the ICAM-1 promoter ( À 1165 to þ 994) into six different fragments (A-F) and prepared the respective luciferase reporter constructs. We also performed the chromatin immunoprecipitation (ChIP) assays for four different regions (R-1 (promoter), R-2 (exon), R-3 (proximal intron-1) and R-4 (distal intron-1). Putative Stat3-binding motifs occurred adjacent to NF-kB-binding sites in R-2 and R-3, whereas the overlapping binding sites occurred in the R-4 region. Based on this promoter study, we reasoned that the Stat3/NF-kB complex is likely to be involved in the modulation of ICAM-1 expression in gliomas. ChIP assays indicated a basal level ICAM-1 regulation by NF-kB/Stat3 interplay D Kesanakurti et al of p65 binding to different regions with the highest binding affinity to R-1 followed by R-3, R-2 and R-4, with no obvious binding recorded to the -ve fragment in the control cells (Figure 4b ). After IR treatment, the p65 occupancy to all the regions was increased, with a maximum increase in R-3 (B16.1-fold; proximal intron-1) followed by R-4 (B9.5-fold; distal intron-1) over basal levels. Stat3 showed more binding affinity towards R-3 followed by R-4 and R-2, whereas no obvious binding occurred to R-1. On the other hand, Stat3 promoter recruitment was significantly increased on R-3 (B15.5-fold), R-4 (B8.5-fold) and R-2 (B3.1-fold) regions in IR-treated cells (Figure 4c ). Luciferase reporter assays showed the highest promoter activity with Fragment F (D þ E), followed by D (proximal intron with adjacent NF-kB-and Stat3-binding sites) and E (distal intron with overlapping NF-kB-, Stat3-elements) of ICAM-1 (Figure 4d ). However, Fragment C (exon with adjacent NF-kB-, Stat3-binding elements) showed no increase in promoter activity compared with intronic Fragments D, E and F. Conversely, both Fragments A and B showed moderate increases in activity in both cell lines (B1.5-2.0-fold). Disruption of putative NF-kB-binding sites in D and E fragments remarkably reduced the promoter activity (Figures 4e  and f) . Similarly, transfections with pGL3 plasmids carrying mutated Stat3 consensus sequences in Fragments D and E significantly inhibited IR-induced promoter activity in both the 4910 and 5310 cell lines (Figure 4g ). These results highlight the potential role of preferential p65/Stat3 recruitment to the intron-1 in IR-induced ICAM-1 activation in glioma.
Coordinated regulation of IR-induced ICAM-1 transactivation by p65 and Stat3 To further assess the biological role of Stat3/NF-kB interaction on ICAM-1 expression and to activate Stat3 and NF-kB, we treated the cells with Stat3C and tumor-necrosis factor (TNF)-a, respectively. In parallel, specific knockdown experiments were also performed using Stat3.si and JSH-23 or p65.siRNA treatments in combination with IR or TNF-a. Preimmnuoprecipitated inputs were subjected to WB to determine Stat3 protein levels. (c) Recombinant GST-p65, GST-Stat3 fusion proteins were separated on SDS-PAGE, transferred to nitrocellulose membrane and visualized by Ponceau staining. In vitro synthesized biotin-labeled Stat3 and p65 truncated proteins were incubated with GST-p65 and GST-Stat3, respectively. Elutes were then subjected to SDS-PAGE, analyzed and representative blots from three independent experiments are presented. Ten percent of the biotin-labeled proteins were loaded as input controls in the binding reaction. (d) Mapping of the minimal interacting regions on p65 and Stat3. Bacterially expressed GST, GST-p65 and GST-Stat3 were purified using MagneGST Pull-Down System following manufacturer's instructions. Biotin-labeled truncated mutants of Stat3 and p65 proteins were synthesized using a TNT Quick Coupled Transcription/Translation Systems as described in Materials and Methods. Labeled-Stat3 mutants were incubated with GST-p65 (top left panel). The mixtures were washed and elutes were SDS-PAGE separated, transferred to nitrocellulose membrane and interacting partners were then detected. Input samples (10% input) were analyzed by SDS-PAGE (bottom left panel). Biotin-labeled p65-truncated proteins were incubated with GST-Stat3 (top right panel). Input samples were analyzed by SDS-PAGE (bottom right panel). (e) Top panel-schematic representations of p65 and its truncation mutants used in GST pull-downs to localize the Stat3 interaction domain within p65. RHD-Rel Homology Domain, TAD Transactivation Domain. Bottom panel-schematic representations of Stat3 and its truncation mutants used in GST pull-down experiments to localize the p65 interaction domain within Stat3. The following domains were represented with corresponding amino-acid positions: ID, interaction domain; CCD, coilied coil domain; DBD, DNA-binding domain; SH2, dimerization domain and TAD, transactivation domain. (f ) EMSA was performed to detect the NF-kB DNA-binding activity. Antibodies specific for p65, Stat3 and p300 were incubated with the control sample before adding labeled probe to observe supershift (SS). Representative blots from three independent experiments are shown.
Individual treatments with IR and TNF-a enhanced nuclear expression levels of p-Stat3, p-p65 and ace-p65 in both the 4910 and 5310 cells. Despite the IR and TNF-a treatments given in Stat3.si þ IR and Stat3.si þ TNF-a, Stat3 downregulation significantly decreased nuclear p-p65 and ace-p65 levels, when compared with scrambled-vectors (pSV) þ IR or pSV þ TNF-a treatments ( Figure 5a ). Additionally, Stat3.si significantly inhibited the IR-and TNF-a-induced ICAM-1 transcription (Supplementary Figure S4a) . WB indicated that the Stat3.si treatment significantly reversed IR-or TNF-a-induced ICAM-1 expression in both the cell lines ( Figure 5b ). The sICAM-1 levels were also decreased by Stat3.si, suggesting the requirement of coordinated regulation of Stat3/NF-kB for IR-induced ICAM-1 upregulation (Figure 5c ). To further evaluate the role of Stat3 in the regulation of p65 recruitment onto the intron-1 of ICAM-1, we performed ChIP assay using R-3 primers. Stat3.si remarkably inhibited the IR-and TNF-ainduced p65 recruitment to the R-3 region (Figure 5d ). This reversal of p65 binding was in correlation with IR-or TNF-ainduced nuclear p-Stat3 expression shown in Figure 5a . Conversely, elevated Stat3 recruitment to the R-3 region was significantly decreased by p65.si treatment in these cells (Figure 5e ). These data suggest the reciprocal regulation between p65 and Stat3 for recruitment on the intron-1 of ICAM-1 in glioma.
Disruption of p65/Stat3 binding inhibited IR-induced ICAM-1-mediated migration and invasion in glioma We next examined the effect of NF-kB suppression on IR-induced Stat3 activation. Stat3C-overexpressing and IR-treated 4910 and 5310 cells showed elevated nuclear p-Stat3, p-p65 and ace-p65 levels ( Figure 6a) . Alternatively, the JSH-23 overturned the Stat3C-and IR-induced p-Stat3 levels, thereby implying that NF-kB suppression led to the depletion of Stat3 in the nucleus. This might be due to a reciprocal nuclear regulation of NF-kB on Stat3 or an indirect effect of NF-kB target protein suppression, including interleukin (IL)-6 or IL-10, which are required to activate Stat3 signaling. In addition, JSH-23 drastically inhibited Stat3C-induced ICAM-1 levels in both the cell lines. Mirroring these results, EMSA results also showed hindrance of NF-kB activity in Stat3-knockdown cells. In addition, Stat3.si counteracted IR-or TNF-a-induced NF-kB activity (Supplementary Figure S4b) . ChIP DNA-binding assays confirmed the significant elevation in p65 recruitment on Figure 2 . Stat3 and NF-kB (p65) nuclear interaction is enhanced in irradiated human glioma xenograft cell lines. (a) The cytoplasmic and nuclear extracts from IR-treated (0-8 Gy) 4910 and 5310 cells were subjected to WB. Blots were reprobed with antibodies against GAPDH (glyceraldehyde 3-phosphate dehydrogenase) and HDAC-1 (histone deacetylase 1) to monitor equal loading of cytoplasmic and nuclear fractions, respectively. (b) The control and IR-treated cells were immunostained to check the expression and sub-cellular distribution of p65 (red) and Stat3 (green). DAPI (4,6-diamidino-2-phenylindole) was used for nuclear counterstaining and representative pictures from three individual experiments are presented. (c) Co-IP experiments were carried out by precipitating the nuclear extracts (500 mg) with non-specific IgG and p-Stat3 antibodies using mMACS protein G microbeads and MACS separation columns following the manufacturer's instructions. WB was carried out using immunoprecipitates. Blots were stripped and reprobed with antibody used for IP to confirm the antibody specificity. Input control samples (50 mg of pre-immunoprecipitated samples) were subjected to IB and input blots were also probed with HDAC-1 to monitor equal loading. (d) IP was performed using p-p65 antibody and immunopecipitates were subjected WB as described above. (e) IP experiments were carried out with ace-p65 antibody. Representative blots from three independent experiments are presented. Figure  S6a) . IR-induced nuclear expression levels of p-p65, p-Stat3 and subsequent elevation in ICAM-1 levels were noticeably decreased in Stat3.si þ IR-treated tumors (Supplementary Figure S6b) . Inhibition of p65/Stat3-mediated ICAM-1 levels in Stat3.si þ IRtreated tumors was in correlation with suppressed tumor growth in vivo (Supplementary Figure S6c) . Figure 8 schematically summarizes the potential mechanism of IR-induced nuclear p65/Stat3 interaction and their eventual binding to ICAM-1 intron-1, with functional significance in enhancing post-IR glioma malignancy. These in vivo studies validate our in vitro findings and established the prominent role of Stat3/NF-kB direct nuclear binding in the ICAM-1-mediated invasion and migration and also 
DISCUSSION
Individually, both NF-kB and Stat3 regulate the expression of a large number of target genes involved in tumor cell proliferation, migration and invasion. The increased number of overlapping target genes regulated by positive or negative crosstalk between NF-kB and Stat3 suggest the requirement of combined targeting therapies of these TFs. [27] [28] [29] [30] Conversely, the potential role of Stat3/ NF-kB interaction in GBM pathogenesis still remains to be investigated. NF-kB is also reported to be involved in a complex formation with several other TFs. In addition to the classical (e) Specific nucleotide mutations (underlined) were incorporated into the putative NF-kB and Stat3 consensus sequences in pGL3-D and pGL3-E vectors using QuikChange II XL Site-Directed Mutagenesis Kit following manufacturer's instructions. (f) Promoter reporter activity assays were performed in IR-treated cells using respective pGL3 vectors as described above. Relative luciferase activities obtained from three experimental replicates are presented as mean ± s.e. and significance indicated by *Po0.05 and **Po0.01. (g) The relative luciferase activities obtained from three independent experiments are shown as mean ± s.e. (*Po0.05 and **Po0.01).
ICAM-1 regulation by NF-kB/Stat3 interplay D Kesanakurti et al
regulation pathway of NF-kB through IkB proteins, recent studies evidenced that an increasing number of proteins, including negative regulators PIAS3 31 and SOCS1 32 as well as positive regulators BRCA1, 33 CAPERa 34 and SP1, 35 interact with and regulate NF-kB. Though earlier studies suggested that p65 binds to the Stat3-DBD (DNA-binding domain), the Stat-binding region within the p65 protein is unidentified. Our studies indicated that Stat3 binds to the p65-TAD and augments NF-kB activity. Previous studies demonstrated the functional significance of SP-1/NF-kB coupling and binding onto the DNMT1 (DNA methyltransferase 1) and KIT (v-kit-Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) oncogene promoter elements. Moreover, treatments with Bortezomib or SP-1 shRNA massively decreased DNMT and/or KIT expression levels in acute myeloid leukemia. 35, 36 The possible functional collaboration between NF-kB/Stat3 in the regulation of several genes, including inducible nitric oxide synthase and T helper type-1, has been reported. 26, 30, [37] [38] [39] [40] However, the NF-kB/Stat3 crosstalk has been reported to repress the IL-6 and IL-12p40 genes. 41 Conversely, our results indicated the cooperative role of NFkB and Stat3 in ICAM-1 activation in glioma. Earlier studies demonstrated the NF-kB/Stat3/PI3K crosstalk in the regulation of the Myc gene, and inhibition of any of these pathways abrogated Myc gene activation. 37 Xue, et al. 25 showed the presence of potential NF-kB-binding elements in intron-1 ( þ 70 and þ 611) of the ICAM-1 gene and demonstrated that the physical interaction and preferential recruitment of p65/NFATc1 was essential for the thrombin-induced ICAM-1 gene expression in endothelial cells.
As GBM tumor recurrence primarily lies in proximity to the field of radiation, any method inhibiting the recurrence of the primary tumor after radiotherapy has potential significance in GBM treatment. 42 Radiation-induced cytotoxic effect is conferred by the induction of DNA double-strand breaks. On the other hand, IRinduced ROS-mediated activation of NF-kB facilitates cells to escape apoptotic elimination, thereby resulting in enhanced malignancy. 11 Based on the previous reports indicating the elevated serum-ICAM-1 levels in GBM patients, it is interesting to study the exact molecular mechanism of ICAM-1 transactivation in irradiated tumor cells. 20, 22 Earlier reports characterized the role of ICAM-1 in tumor malignancy and addressed the importance of inducible TF-binding sites in the ICAM-1 promoter. 25, 43 The presence of consensus binding sites for different TFs, including Ap1, Ets, NF-kB, c/EBP, TRE, AP2 and AP3 and Stat1, in the ICAM-1 promoter were identified previously. 44, 45 The TNF-a-and lipopolysaccharide-induced ( À 187 and À 178) and thrombininduced ( À 231 to À 211) binding of the p65/RelA homodimer has been shown to be essential for the activation of ICAM-1 in endothelial cells. 24, 46 We analyzed the ICAM-1 5 0 regulatory region for the presence of TF consensus elements and studied the significance of occurrence of both NF-kB and Stat3-binding sites in the intron-1. Further, disruption of either NF-kB-or Stat3-binding sequences in D (proximal intron-1) or E (distal intron-1) fragments significantly abrogated the promoter activity and inhibited Stat3 and p65 promoter recruitment. The distal intronic region containing 
MATERIALS AND METHODS
Cell culture, reagents, irradiation and transfection studies
Human glioma xenograft cell lines 4910 and 5310 (generously provided by Dr David James, University of California, San Francisco), which are highly invasive in the mouse brain, were developed and maintained in mice. 47 Cells were cultured in RPMI 1640 (Mediatech Inc., Herndon, VA, USA) supplemented with 10% fetal bovine serum (Invitrogen, Carlsbad, CA, USA), 50 units/ml penicillin, and 50 mg/ml streptomycin. Human astrocytes were cultured in astrocyte medium augmented with 2% fetal bovine serum, 1% penicillin/streptomycin and 1% astrocyte growth supplements (Sciencell Research Laboratories, Carlsbad, CA, USA). Human glioma cell lines U87MG, U251 and SNB19 were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Transient transfections (24 h) were performed after 6 h serum starvation using mock (1 Â phosphate-buffered saline), pcDNA3.0-Stat3.siRNA (Stat3.si, 5 0 -gcag tttcttcagagcaggtagagtcgtcgtacctgctctgaagaaactgc-3 0 ), ICAM-1.siRNA (Santa Cruz Biotechnology, Santa Cruz, CA, USA), SignalSilence NF-kB p65 siRNA (No. 6261, Cell Signaling Technology, Boston, MA, USA) or non-target pSV using FuGene HD transfection reagent following the manufacturer's instructions (Roche Applied Science, Indianapolis, IN, USA). We developed constitutively active Stat3C (Addgene: plasmid 8722; Bromberg et al.
17
) stable 4910 and 5310 cells following the procedure described earlier. 48 Cells were irradiated with different doses (Gy) using a RS2000 Biological Irradiator (Rad Source Technologies Inc., Boca Raton, FL, USA). For combination treatments, cells were either treated with TNF-a (10 ng/ml) or 10 mM JSH-23 (NF-kB Activation Inhibitor II) or recombinant human ICAM-1 protein (rhICAM-1, 2 mg/ml) at 18 h post-transfection incubated for another 6 h and harvested. We used TNF-a, JSH-23 (Calbiochem, La Jolla, CA, USA) and recombinant human ICAM-1 protein (rhICAM-1; Novus Biologicals, Littleton, CO, USA). We used p-p65 (Ser 536), p-Stat3 (Tyr 705), ICAM-1, GAPDH, phospho-Tyrosine, HDAC-1, and horseradish peroxidase/Alexa Fluor-conjugated secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA). We also used acetyl-p65-K310 (Abcam, Cambridge, MA, USA), NF-kB (p65)a, Stat3a, p300 and anti-FLAG (DYKDDDDK Tag) antibodies (Cell Signaling Technology, Boston, MA, USA) in our study.
Quantitative-PCR and ChIP assay
Quantitative reverse transcriptase-PCR was performed as described earlier 32 In vitro transcription and translation and GST pull-down assays Various truncated mutants of p65 and Stat3 were in vitro synthesized from specific PCR-amplified fragments using Transcend Biotin-Lysyl-tRNA and TnT Quick Coupled Transcription/Translation System (Promega) following the manufacturer's instructions. The full-length PCR-amplified fragments of Stat3 (EcoRI and SalI) and p65 (BamHI and XhoI) were sub-cloned in pGEX-5X-1 (GE Healthcare, Piscataway, NJ), sequencing verified, following the induction of log-phase cultures of E. coli (DH5a) in LB media with 1.0 mg/ ml IPTG for 6-12 h at 30 1C. Recombinant GST-fusion proteins GST-p65, GST-Stat3 and GST were purified using MagneGST Pull-Down System (Promega) following manufacturer's protocol and verified by SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis). The aliquotes of diluted protein-packed GST particles (B2 mg) were incubated with biotin-labeled p65 and Stat3 truncated proteins overnight at 4 1C. Beads were washed thoroughly, eluted in 20 ml of pre-heated sample buffer, SDS-PAGE separated, transferred to nitrocellulose membrane and detected using Transcend Non Radioactive Translation Detection Systems following manufacturer's instructions (Promega).
Nuclear/cytoplasmic protein fractionation, WB and co-IP Whole-cell lysates and conditioned media were prepared as described previously. 49 The nuclear and cytoplasmic extracts in cells and tissue samples were fractionated using NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo Scientific, Rockford, IL, USA) following the manufacturer's instructions. Membrane proteins were extracted using the MEM-PER Eukaryotic Membrane Protein Extraction Kit (Pierce Biotechnology, Inc., Rockford, IL, USA) following the manufacturer's instructions. Co-IP was performed with nuclear extracts (500 mg) incubated with p-p65, p-Stat3, ace-p65-K310 or non-specific-IgG (NspIgG) antibodies using mMACS protein-G microbeads and MACS Separation Columns following the manufacturer's instructions (Miltenyi Biotec, Auburn, CA, USA). 49 
EMSA
EMSA assays for determining p65 DNA binding were performed using Panomics EMSA Kit (Panomics, Inc., Fremont, CA) following the manufacturer's instructions. 48 For supershift, each antibody (2 mg) was pre-incubated with nuclear protein for 30 min before the addition of the labeled probe.
Wound healing migration and Matrigel invasion assays
For wound healing migration assay, cells were treated as described above for 24 h. By considering this point as 0 h, a straight scratch was made in individual wells using a 200-ml pipette-tip, and after 12 h, the plates were microscopically observed for wound healing, and the average cell migration distances were measured using a microscope calibrated with an ocular micrometer (Olympus1X71, Center Valley, PA, USA). Matrigel invasion assay was performed as described earlier. 50 
Immunofluorescence and immunohistochemical analyses
The immunocytochemical and immunohistochemical analyses were performed exactly as described earlier. 51 Figure 8. Schematic representation of direct nuclear interaction and reciprocal regulation of NF-kB (p65) and Stat3 in glioma. IR treatment increased phosphorylation of both p65 and Stat3, which eventually translocate into the nucleus. In the nucleus, CBP/p300 acetyl transferases bind to the p-p65, transfer acetyl group and acetylate p65. The p-Stat3 directly interacts with p-p65 at transactivation domain and forms p-p65/p-Stat3 complex in the nucleus. IR elevates the p-p65/p-Stat3 complex formation and subsequent binding to the adjacent NF-kB (þ 399) and Stat3 ( þ 479) consensus sequences in the ICAM-1 intron-1. As a result, there is a significant increase in ICAM-1 transcription, membrane localization and an increase in sICAM-1 levels in the extracellular milieu of IR-treated cells. This mechanism leads to enhanced adhesion, invasion and migratory properties in post-irradiated cells. On the other hand, the p65/Stat3 interactions were abrogated by specific siRNA-mediated knock down of p65 and Stat3. IR-induced ICAM-1 upregulation, cell invasion and migration were abrogated by using ICAM-1.siRNA. In summary, our results demonstrated that the elevated functional association of p65 and Stat3 as a function of IR in enhancing glioma malignancy through ICAM-1 upregulation. Hence, blockade of p65 and Stat3 binding provides a potential therapeutic approach in the future treatment of glioma. TSS, transcription start site. 
